S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
OTCMKTS:SMLR

Semler Scientific Stock Forecast, Price & News

$96.56
-0.42 (-0.43%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$95.99
$98.98
50-Day Range
$93.10
$149.99
52-Week Range
$70.20
$153.21
Volume
20,428 shs
Average Volume
24,405 shs
Market Capitalization
$652.55 million
P/E Ratio
37.14
Dividend Yield
N/A
Beta
0.76
30 days | 90 days | 365 days | Advanced Chart
Receive SMLR News and Ratings via Email

Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter.


Semler Scientific logo

About Semler Scientific

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.

Headlines

Semler Scientific (OTCMKTS:SMLR) PT Lowered to $145.00
November 2, 2021 |  americanbankingnews.com
Semler Scientific (OTCMKTS:SMLR) Price Target Cut to $175.00
November 2, 2021 |  americanbankingnews.com
Recap: Semler Scientific Q3 Earnings
November 1, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SMLR
Previous Symbol
NASDAQ:SMLR
Fax
N/A
Employees
86
Year Founded
N/A

Sales & Book Value

Annual Sales
$38.60 million
Cash Flow
$1.85 per share
Book Value
$6.51 per share

Profitability

Net Income
$14.01 million
Pretax Margin
45.19%

Debt

Price-To-Earnings

Miscellaneous

Free Float
5,866,000
Market Cap
$652.55 million
Optionable
Not Optionable

Company Calendar

Last Earnings
10/31/2021
Today
11/27/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

2.19 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Semler Scientific (OTCMKTS:SMLR) Frequently Asked Questions

Is Semler Scientific a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Semler Scientific in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Semler Scientific stock.
View analyst ratings for Semler Scientific
or view top-rated stocks.

How has Semler Scientific's stock price been impacted by Coronavirus (COVID-19)?

Semler Scientific's stock was trading at $45.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SMLR shares have increased by 114.6% and is now trading at $96.56.
View which stocks have been most impacted by COVID-19
.

How were Semler Scientific's earnings last quarter?

Semler Scientific, Inc. (OTCMKTS:SMLR) announced its earnings results on Sunday, October, 31st. The medical equipment provider reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.65 by $0.14. Semler Scientific had a trailing twelve-month return on equity of 56.71% and a net margin of 39.41%.
View Semler Scientific's earnings history
.

What guidance has Semler Scientific issued on next quarter's earnings?

Semler Scientific issued an update on its third quarter earnings guidance on Monday, November, 1st. The company provided earnings per share guidance of $0.51 for the period, compared to the Thomson Reuters consensus estimate of $0.70. The company issued revenue guidance of $14 million, compared to the consensus revenue estimate of $15.06 million.

What price target have analysts set for SMLR?

3 Wall Street analysts have issued twelve-month price targets for Semler Scientific's shares. Their forecasts range from $145.00 to $181.00. On average, they anticipate Semler Scientific's stock price to reach $167.00 in the next twelve months. This suggests a possible upside of 72.9% from the stock's current price.
View analysts' price targets for Semler Scientific
or view top-rated stocks among Wall Street analysts.

Who are Semler Scientific's key executives?

Semler Scientific's management team includes the following people:
  • Douglas R. Murphy-Chutorian, Chief Executive Officer, Secretary & Director (LinkedIn Profile)
  • Andrew B. Weinstein, Senior Vice President-Finance & Accounting
  • Robert G. McRae, Chief Technical Officer
  • Daniel E. Conger, Vice President-Finance
  • Dennis Rosenberg, Chief Marketing Officer

What other stocks do shareholders of Semler Scientific own?

What is Semler Scientific's stock symbol?

Semler Scientific trades on the OTCMKTS under the ticker symbol "SMLR."

Who are Semler Scientific's major shareholders?

Semler Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include Park West Asset Management LLC (8.24%), Opaleye Management Inc. (3.34%), Aravt Global LLC (2.32%), Goldman Sachs Group Inc. (2.23%), Iridian Asset Management LLC CT (0.59%) and Apis Capital Advisors LLC (0.51%). Company insiders that own Semler Scientific stock include Douglas Murphy-Chutorian, HC Chang & Diana Sho William and Wayne T Pan.
View institutional ownership trends for Semler Scientific
.

Which institutional investors are buying Semler Scientific stock?

SMLR stock was purchased by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, Opaleye Management Inc., Aravt Global LLC, Goldman Sachs Group Inc., Iridian Asset Management LLC CT, Apis Capital Advisors LLC, Avalon Investment & Advisory, and Parkman Healthcare Partners LLC.
View insider buying and selling activity for Semler Scientific
or or view top insider-buying stocks.

How do I buy shares of Semler Scientific?

Shares of SMLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Semler Scientific's stock price today?

One share of SMLR stock can currently be purchased for approximately $96.56.

How much money does Semler Scientific make?

Semler Scientific has a market capitalization of $652.55 million and generates $38.60 million in revenue each year. The medical equipment provider earns $14.01 million in net income (profit) each year or $2.60 on an earnings per share basis.

How many employees does Semler Scientific have?

Semler Scientific employs 86 workers across the globe.

What is Semler Scientific's official website?

The official website for Semler Scientific is www.semlerscientific.com.

Where are Semler Scientific's headquarters?

Semler Scientific is headquartered at 911 BERN COURT SUITE 110, SAN JOSE CA, 95112.

How can I contact Semler Scientific?

Semler Scientific's mailing address is 911 BERN COURT SUITE 110, SAN JOSE CA, 95112. The medical equipment provider can be reached via phone at (877) 774-4211 or via email at [email protected].


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.